Investigating the Presence of blaCMY and Extended Spectrum Beta-Lactamase Genes in Klebsiella pneumoniae Isolates Identified in the Clinical Samples of Patients in Dhi-Qar, Iraq

سال انتشار: 1403
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 147

فایل این مقاله در 6 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_JCMI-11-3_003

تاریخ نمایه سازی: 12 آذر 1403

چکیده مقاله:

Background: Klebsiella pneumoniae is an opportunistic pathogen that can cause nosocomial infections due to its high virulence factors and multiple antimicrobial resistance (AMR) mechanisms. This bacterium can produce various beta-lactamases, including extended-spectrum beta-lactamase (ESBL) and AmpC. This study aimed to investigate the presence of plasmid AmpC and ESBL genes in K. pneumoniae isolates from the clinical samples of patients in Dhi-Qar, Iraq. Methods: A total of ۶۱۲ clinical samples were collected from different medical centers and laboratories in Dhi-Qar, Iraq, between April ۲۰۲۳ and February ۲۰۲۴. Then, the presence of K. pneumoniae in these samples was evaluated using conventional biochemical and microbiological methods. ESBL production was assessed phenotypically by the synergy double disk (SDD) method. The presence of the blaCTX-M, blaTEM, blaCTX-M-۳, blaCMY, and blaSHV genes was analyzed using the polymerase chain reaction. Results: Out of the ۶۱۲ samples, ۱۸۰ (۲۹.۴%) tested positive for K. pneumoniae. Of these, ۴۰ isolates (۲۲.۲%) were positive in the SDD test and were considered ESBL producers. The blaSHV, blaCTX-M-۳, blaTEM, and blaCTX-M genes were detected in ۸ (۲۰%), ۳۲ (۸۰%), ۲۱ (۵۲.۵%), and ۲۲ (۵۵%) isolates, respectively. The blaCMY gene was not found in any of the K. pneumoniae isolates. Conclusion: Our study highlights high resistance against third-generation cephalosporins among K. pneumoniae isolates. The prevalence of ESBL genes, including blaCTX-M, blaTEM, and blaSHV, among these isolates can cause serious challenges in the treatment of bacterial infections.